Loading...
Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: An Open-Label Study
BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are novel agents used to treat type 2 diabetic patients. We investigated the efficacy of the SGLT2 inhibitor ipragliflozin on diabetic nephropathy in Japanese patients with type 2 diabetes. METHODS: A 50 mg dose of ipragliflozin was admin...
Na minha lista:
| Udgivet i: | J Clin Med Res |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elmer Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215019/ https://ncbi.nlm.nih.gov/pubmed/28090231 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2875w |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|